BOT price action, page-1546

I'm reflecting on this and, to put as best a light on as I can:

> BTX 1503 [overall, promising], initial mixed results, but appears to be due to US contingent using an older candidate technology. Goal is to move into PhIII

> BTX 1204 Dead duck

> Other programs remain active.

So, best light [current] scenario, we're a biotech company, with multiple programs working their way through.

Today was simply not one of the better days for BOT, one of our programs died. Frustrating and costly for shareholders.....but not necessarily the final chapter......IF you continue to believe in the story, cheap shares are there for the taking.